Qin H, Han Y, Li J, Wu Q, Du Y, Li Q
NPJ Precis Oncol. 2025; 9(1):65.
PMID: 40057617
PMC: 11890584.
DOI: 10.1038/s41698-025-00840-w.
Marton E, Varga A, Domoszlai D, Buglyo G, Balazs A, Penyige A
Cancers (Basel). 2025; 17(4).
PMID: 40002172
PMC: 11853212.
DOI: 10.3390/cancers17040579.
Li S, Guo M, Long Y, Cai Y, Zhao Y, Huang S
Clin Transl Med. 2025; 15(3):e70260.
PMID: 40000424
PMC: 11859124.
DOI: 10.1002/ctm2.70260.
Cai J, Yan Z, Zhong Y, Li Y, Huang J, Hu H
BMC Cancer. 2025; 25(1):319.
PMID: 39984879
PMC: 11846270.
DOI: 10.1186/s12885-025-13672-5.
Taghizadeh-Teymorloei M, Jafarlou V, Matin S, Raeisi M, Roosta Y, Mansouri-Derakhshani S
Clin Transl Oncol. 2025; .
PMID: 39969763
DOI: 10.1007/s12094-025-03863-8.
piR-26441 inhibits mitochondrial oxidative phosphorylation and tumorigenesis in ovarian cancer through m6A modification by interacting with YTHDC1.
Yuan J, Xie B, Ji Y, Bao H, Wang J, Cheng J
Cell Death Dis. 2025; 16(1):25.
PMID: 39827178
PMC: 11742951.
DOI: 10.1038/s41419-025-07340-6.
pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation.
Liao Z, Yang L, Cheng X, Huang X, Zhang Q, Wen D
Cell Death Discov. 2025; 11(1):11.
PMID: 39824843
PMC: 11742400.
DOI: 10.1038/s41420-024-02285-9.
Unraveling the microRNAs Involved in Fasciolosis: Master Regulators of the Host-Parasite Crosstalk.
Barrero-Torres D, Herrera-Torres G, Perez J, Martinez-Moreno A, Martinez-Moreno F, Flores-Velazquez L
Int J Mol Sci. 2025; 26(1.
PMID: 39796061
PMC: 11719827.
DOI: 10.3390/ijms26010204.
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.
Benacka R, Szaboova D, Gulasova Z, Hertelyova Z
Int J Mol Sci. 2025; 26(1.
PMID: 39795985
PMC: 11719911.
DOI: 10.3390/ijms26010127.
Somatic piRNA and PIWI-mediated post-transcriptional gene regulation in stem cells and disease.
Patel M, Jiang Y, Kakumani P
Front Cell Dev Biol. 2024; 12:1495035.
PMID: 39717847
PMC: 11663942.
DOI: 10.3389/fcell.2024.1495035.
Small RNA sequencing data of plasma extracellular vesicles in a breast cancer screening population.
Mo J, Li X, Lei L, Liang X, Zhou H, Liu Z
Sci Data. 2024; 11(1):1381.
PMID: 39695198
PMC: 11655662.
DOI: 10.1038/s41597-024-04164-5.
Targeting piRNA-137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma.
Zhan Y, Tian F, Fan W, Li X, Wang X, Zhang H
Adv Sci (Weinh). 2024; 12(6):e2414100.
PMID: 39692168
PMC: 11809383.
DOI: 10.1002/advs.202414100.
Influence of aging and maternal protein restriction on PIWI-interacting RNA expression in the offspring rat ventral prostate.
Baptista H, Portela L, Fioretto M, Mattos R, Ribeiro I, Lorente A
Sci Rep. 2024; 14(1):30372.
PMID: 39639045
PMC: 11621812.
DOI: 10.1038/s41598-024-77901-w.
Mechanisms Behind the Impact of PIWI Proteins on Cancer Cells: Literature Review.
Limanowka P, Ochman B, Swietochowska E
Int J Mol Sci. 2024; 25(22).
PMID: 39596284
PMC: 11594409.
DOI: 10.3390/ijms252212217.
A machine learning model revealed that exosome small RNAs may participate in the development of breast cancer through the chemokine signaling pathway.
Mo J, Li X, Lei L, Peng J, Liang X, Zhou H
BMC Cancer. 2024; 24(1):1435.
PMID: 39574053
PMC: 11580650.
DOI: 10.1186/s12885-024-13173-x.
The Use of Next-Generation Sequencing in Personalized Medicine.
Popova L, Carabetta V
Methods Mol Biol. 2024; 2866:287-315.
PMID: 39546209
DOI: 10.1007/978-1-0716-4192-7_16.
Role of non-coding RNA in lineage plasticity of prostate cancer.
Tan W, Xiao C, Ma M, Cao Y, Huang Z, Wang X
Cancer Gene Ther. 2024; 32(1):1-10.
PMID: 39496938
DOI: 10.1038/s41417-024-00834-z.
Correlating tissue and plasma‑specific piRNA changes to predict their possible role in pancreatic malignancy and chronic inflammation.
Saha B, Chakravarty S, Ray S, Saha H, Das K, Ghosh I
Biomed Rep. 2024; 21(6):186.
PMID: 39420923
PMC: 11484194.
DOI: 10.3892/br.2024.1874.
piRNA in Machine-Learning-Based Diagnostics of Colorectal Cancer.
Li S, Kouznetsova V, Kesari S, Tsigelny I
Molecules. 2024; 29(18).
PMID: 39339306
PMC: 11434383.
DOI: 10.3390/molecules29184311.
DNA damage response-related ncRNAs as regulators of therapy resistance in cancer.
Gao Z, Luan X, Wang X, Han T, Li X, Li Z
Front Pharmacol. 2024; 15:1390300.
PMID: 39253383
PMC: 11381396.
DOI: 10.3389/fphar.2024.1390300.